AR013165A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE

Info

Publication number
AR013165A1
AR013165A1 ARP980103209A ARP980103209A AR013165A1 AR 013165 A1 AR013165 A1 AR 013165A1 AR P980103209 A ARP980103209 A AR P980103209A AR P980103209 A ARP980103209 A AR P980103209A AR 013165 A1 AR013165 A1 AR 013165A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
compositions containing
eletriptan hemisulphate
containing eletriptan
hemisulphate
Prior art date
Application number
ARP980103209A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR013165A1 publication Critical patent/AR013165A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Abstract

La presente invencion proporciona una composicion farmacéutica acuosa que comprende de 5 a 200 mg/ml de eletriptán hemisulfato y del 0,5 a 2,0%en peso/volumen de cafeína.The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg / ml eletriptan hemisulfate and 0.5 to 2.0% w / v caffeine.

ARP980103209A 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE AR013165A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR013165A1 true AR013165A1 (en) 2000-12-13

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103209A AR013165A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE

Country Status (13)

Country Link
KR (1) KR100384346B1 (en)
AP (1) AP1100A (en)
AR (1) AR013165A1 (en)
CO (1) CO4950555A1 (en)
GB (2) GB9714081D0 (en)
GT (1) GT199800105A (en)
HN (1) HN1998000101A (en)
MY (1) MY119643A (en)
PA (1) PA8454501A1 (en)
PE (1) PE84499A1 (en)
TN (1) TNSN98126A1 (en)
UA (1) UA49955C2 (en)
ZA (1) ZA985812B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AP9801290A0 (en) 1998-09-30
UA49955C2 (en) 2002-10-15
ZA985812B (en) 2000-01-10
AP1100A (en) 2002-09-02
MY119643A (en) 2005-06-30
KR100384346B1 (en) 2003-05-16
GB9714081D0 (en) 1997-09-10
PA8454501A1 (en) 2000-05-24
GT199800105A (en) 2000-01-04
TNSN98126A1 (en) 2005-03-15
PE84499A1 (en) 1999-09-11
CO4950555A1 (en) 2000-09-01
KR20010014366A (en) 2001-02-26
GB9718270D0 (en) 1997-11-05
HN1998000101A (en) 1999-01-08

Similar Documents

Publication Publication Date Title
ES2163291T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULFATE AND CAFFEINE.
PA8453201A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
ES2181055T3 (en) GALENIC FORMULATIONS CONTAINING OPTIACE ANTAGONISTS.
HN1999000066A (en) PHARMACEUTICAL FORMULATIONS
AR015379A1 (en) ASCORBIL-FOSFORIL-CHOLESTEROL
BR9810495A (en) Pharmaceutical composition
ES2181501T3 (en) COSMETIC COMPOSITION.
CO4770947A1 (en) ANTIMICROBIAL COMPOSITIONS CONTAINING C3-C6 ALCOHOL
ES2180573T3 (en) USE OF INDOL DERIVATIVES AS 5HT1 ANTAGONISTS.
ES2187489T3 (en) DICLOFENAC BASED PHARMACEUTICAL COMPOSITIONS.
ATE245028T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIMEGESTONE
ES2191625T3 (en) ORAL COMPOSITION CONTAINING PERLITA.
AR013165A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE
ECSP982578A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE
HN2000000057A (en) DERIVATIVES OF I - TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL- AMINOMETILCROMANO.
BR9907195A (en) "prolonged-release tiagabine formulations with reduced side effects"
AR023056A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON ALFA-CYCLODEXTRINE FOR THE ORAL ADMINISTRATION OF ANALOGS OF LH-RH
ES2175086T3 (en) ANTI-EMETIC PHARMACEUTICAL COMPOSITIONS CONTAINING METOTRIMEPRAZINE.
GT199800086A (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE.
HN1997000108A (en) DERIVATIVE 6,6,6.6.7- SUBSTITUTED BICYCLES CONTAINING PIRIDO OR PIRIMIDO
DE50006408D1 (en) PHARMACEUTICAL PREPARATION CONTAINING DITHRANOL
ECSP982538A (en) PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE
ECSP982747A (en) NEW FORMULATIONS OF THE PAROXETINE ANTIDEPRESSANT
HN1999000201A (en) DERIVATIVES OF 3,3 BIARILPIPERIDINA AND 2,2 - BIARILMORFOLINA
GT199400041A (en) DERIVATIVES OF N4 (SUBSTITUTED OXICARBONYL) -5'DESOXI-5-FLUOROCITIDINE

Legal Events

Date Code Title Description
FB Suspension of granting procedure